The independent expert screening committee has recommended that bowel cancer screening in England should in future start at age 50 to prevent late diagnosis
Angela Culhane, Prostate Cancer UK Chief Executive discusses the tools needed to create a screening programme to stop prostate cancer killing men.
Sir Harpal Kumar, former CEO of Cancer Research UK, outlines his vision for cancer in the future and said that earlier diagnosis would enable the UK to catch up with its international counterparts in terms of survival rates and would also make the NHS more efficient
Bethany Torr, Campaigns and Advocacy Officer at Leukaemia Care explores the challenges of living with acute myeloid leukaemia (AML)
Roger Wotton, Chairman of Tackle Prostate Cancer explores the key issues around prostate cancer, the most common cancer in men.
Identifying the molecular signalling pathways leading to advanced prostate cancer to improve therapy and diagnosis
Data from Public Health England shows that cancer diagnosis could impact upon which kind of treatment a patient receives.
Professor Ghulam Nabi from the University of Dundee explores the subject of the enigmatic prostate cancer, with different shades
Ambitious new plans set out by the Prime Minister today will see around 22,000 fewer people dying from cancer each year by 2033
Prime Minister Theresa May has announced a further £75m in funding for “earlier and faster” diagnosis and treatment of prostate cancer, which kills more than 10,000 men each year
Europa Uomo – European Prostate Cancer Coalition Secretary, John Dowling shares his thoughts on the prostate gland, described as a most troublesome piece of tissue.
Researchers have identified a new stem cell pathway that allows triple-negative breast cancer to thrive, with their findings potentially pointing the way towards more effective treatments
Chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML): Leukaemia patients watching and worrying
Bethany Torr, campaigns and advocacy officer at Leukaemia Care discusses the impact of chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML) on patients
The need for supportive care in oncology will increase as patients continue to live longer and cancer progresses to become more like a chronic...
Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research gives an in-depth perspective on acute myeloid leukaemia (AML) and cytarabine pharmacogenomics Acute myeloid...
Dr Miranda Fidler from the International Agency for Research on Cancer highlights the burden of cancer and the need for prevention, diagnosis, and care Cancer...
All.Can shares their profound insights into the challenges concerning the need to improve the efficiency of cancer care, focusing on better outcomes for patients Healthcare...
Experts from the Lymphoma Association offer their thoughts on the extent of lymphoma in the UK today and how treatment and diagnosis can improve Every...
Cecilia Van Cauwenberghe, Vandana Iyer and Bhargav Rajan from Frost & Sullivan examine of how nanotechnology helps spot early stage cancer
Science Information Officer Dr Catherine Pickworth outlines the work being carried out by Cancer Research UK to fight against pancreatic cancer